Home/Filings/4/0001437749-25-037747
4//SEC Filing

Erdogan-Trinkaus Ipek 4

Accession 0001437749-25-037747

CIK 0001710340other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 4:57 PM ET

Size

5.2 KB

Accession

0001437749-25-037747

Insider Transaction Report

Form 4
Period: 2025-12-11
Erdogan-Trinkaus Ipek
Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2025-12-12$16.90/sh85$1,4362,403 total
Footnotes (3)
  • [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
  • [F2]The shares were sold in multiple trades at prices ranging from $16.90 to $16.91. The price reported above reflects the weighted average sales price.
  • [F3]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Issuer

Eton Pharmaceuticals, Inc.

CIK 0001710340

Entity typeother

Related Parties

1
  • filerCIK 0002047026

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:57 PM ET
Size
5.2 KB